The novel approach of this peptide represents a significant breakthrough in the care of type 2 diabetes. Distinct from existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide300249.tblogz.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-55286575